Woman's World on MSN15 小时
Is Your Toothache Actually a Sinus Infection? How to Tell—and Treat It
Sinus infections (also known as sinusitis) strike more than 30 million Americans each year. And if you’re one of them, you’re ...
FDA proposes ending use of popular decongestant present in cold medicines
The US Food and Drug Administration has proposed to remove oral phenylephrine, widely used in cold and cough syrups.
TEZSPIRE MET BOTH CO-PRIMARY ENDPOINTS IN PHASE 3 TRIAL FOR CHRONIC RHINOSINUSITIS WITH ...
Amgen (NASDAQ:AMGN) and AstraZeneca today announced positive top-line results from the Phase 3 WAYPOINT trial in patients ...
FDA Proposes Oral Phenylephrine Shouldn't Be Used in OTC Nasal-Congestion Drugs
Oral phenylephrine, a common nasal-congestion ingredient in over-the-counter drugs, shouldn't be used in monograph drug products, the Food and Drug Administration is proposing. The agency said a ...
U.S. FDA proposes ending use of popular decongestant present in cold medicines
The U.S. Food and Drug Administration has proposed to remove oral phenylephrine, widely used in cold and cough syrups, as an ...
NBC News on MSN14 小时
FDA proposes ending use of decongestant found in many cold, allergy medicines
The agency said an extensive review of available data determined that the ingredient, oral phenylephrine, doesn’t actually ...
Detroit News3 小时
Dr. Roach: Nasal decongestant causes a noticeable strain when urinating
I take 5 mg of Crestor and a multivitamin daily. I recently took a generic 12-hour, maximum-strength nasal decongestant to ...
Are Sinus Infections Contagious? Here's What 3 MDs Have to Say
A sinus infection, also known as sinusitis, occurs when the air cavities around your nasal passages become inflamed and ...
来自MSN8 小时
These Over-The-Counter Decongestants Don't Work, FDA Says
A common ingredient found in most oral over-the-counter cold medicines should be removed from the market because it doesn’t ...
After decades, FDA finally moves to pull ineffective decongestant off shelves
In a long-sought move, the Food and Drug Administration on Thursday formally began the process of abandoning oral doses of a ...
FDA Proposes Ending Use of Oral Phenylephrine as OTC Monograph Nasal Decongestant Active ...
Today, the U.S. Food and Drug Administration announced it is proposing to remove oral phenylephrine as an active ingredient that can be used in over-the-counter (OTC) monograph drug products for the ...